We therefore investigated whether ELK1 could affect the viability and migration of AR-positive bladder cancer cells in the absence of androgens and whether androgen could enhance the viability and migration of AR-positive ELK1-shRNA-expressing bladder cancer cells. Here, ELK1 is linked to urinary bladder carcinoma.